KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) Other Operating Expenses (2016 - 2025)

Elevance Health (ELV) has disclosed Other Operating Expenses for 17 consecutive years, with $40.8 billion as the latest value for Q1 2025.

  • Quarterly Other Operating Expenses rose 17.39% to $40.8 billion in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $40.8 billion through Dec 2025, up 16.71% year-over-year, with the annual reading at $201.0 million for FY2024, N/A changed from the prior year.
  • Other Operating Expenses for Q1 2025 was $40.8 billion at Elevance Health, up from -$39.0 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $40.8 billion in Q1 2025, with the low at -$39.0 million in Q3 2024.
  • Average Other Operating Expenses over 5 years is $27.4 billion, with a median of $31.4 billion recorded in 2022.
  • The sharpest move saw Other Operating Expenses grew 25.41% in 2021, then decreased 0.0% in 2024.
  • Over 5 years, Other Operating Expenses stood at $30.9 billion in 2021, then rose by 11.11% to $34.3 billion in 2022, then grew by 1.27% to $34.8 billion in 2023, then plummeted by 100.11% to -$39.0 million in 2024, then soared by 104700.0% to $40.8 billion in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $40.8 billion, -$39.0 million, and $240.0 million for Q1 2025, Q3 2024, and Q2 2024 respectively.